tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VIR Stock Latest News

Mirum’s deal for Bluejay a positive readthrough to Vir, says Needham
The FlyMirum’s deal for Bluejay a positive readthrough to Vir, says Needham
5d ago
VIR
GILD
Vir Biotechnology’s HDV Program: A Promising Investment Opportunity Amidst Market Underappreciation
PremiumRatings
Vir Biotechnology’s HDV Program: A Promising Investment Opportunity Amidst Market Underappreciation
6d ago
VIR
Vir Biotechnology announces Week 48 endpoint analysis of Phase 2 SOLSTICE
PremiumThe Fly
Vir Biotechnology announces Week 48 endpoint analysis of Phase 2 SOLSTICE
1M ago
VIR
Vir Biotechnology’s Earnings Call: Achievements and Challenges
PremiumCompany Announcements
Vir Biotechnology’s Earnings Call: Achievements and Challenges
1M ago
VIR
Positive Outlook for Vir Biotechnology: Buy Rating Driven by Promising Pipeline Developments and Strong Cash Position
PremiumRatings
Positive Outlook for Vir Biotechnology: Buy Rating Driven by Promising Pipeline Developments and Strong Cash Position
1M ago
VIR
3 Best Stocks to Buy Now, 11/6/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 11/6/2025, According to Top Analysts
1M ago
VIR
Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating
Premium
Ratings
Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating
1M ago
VIR
Vir Biotechnology: Strong Financials and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financials and Promising Clinical Developments Drive Buy Rating
1M ago
VIR
Vir Biotechnology Reports Q3 2025 Financial Results and Clinical Progress
PremiumCompany Announcements
Vir Biotechnology Reports Q3 2025 Financial Results and Clinical Progress
1M ago
VIR
Vir Biotechnology reports Q3 EPS $1.17), consensus (86c)
PremiumThe Fly
Vir Biotechnology reports Q3 EPS $1.17), consensus (86c)
1M ago
VIR
Vir Biotechnology completes enrollment in ECLIPSE 1 trial
PremiumThe Fly
Vir Biotechnology completes enrollment in ECLIPSE 1 trial
1M ago
VIR
Vir Biotechnology’s Innovative HDV Study: A Potential Game-Changer in Viral Treatment
PremiumCompany Announcements
Vir Biotechnology’s Innovative HDV Study: A Potential Game-Changer in Viral Treatment
2M ago
VIR
Vir Biotechnology’s Promising Phase 3 Study for Chronic HDV Treatment
PremiumCompany AnnouncementsVir Biotechnology’s Promising Phase 3 Study for Chronic HDV Treatment
2M ago
VIR
Vir Biotechnology’s Phase 3 Study on HDV Treatment: A Potential Game-Changer?
Premium
Company Announcements
Vir Biotechnology’s Phase 3 Study on HDV Treatment: A Potential Game-Changer?
2M ago
VIR
Vir Biotechnology’s Innovative Approach in HER2-Expressing Cancer Treatment: A Study Update
Premium
Company Announcements
Vir Biotechnology’s Innovative Approach in HER2-Expressing Cancer Treatment: A Study Update
2M ago
VIR
Vir Biotechnology’s Promising Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Vir Biotechnology’s Promising Prostate Cancer Study: A Potential Game-Changer?
2M ago
VIR
Vir Biotechnology’s Phase 1 Study on VIR-5525: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Vir Biotechnology’s Phase 1 Study on VIR-5525: A Potential Game-Changer in Cancer Treatment?
2M ago
VIR
Vir Biotechnology’s Hepatic Impairment Study: A Potential Game Changer?
PremiumCompany Announcements
Vir Biotechnology’s Hepatic Impairment Study: A Potential Game Changer?
2M ago
VIR
Vir Biotechnology doses first patient in Phase 1 part 3 trial of VIR-5500
PremiumThe Fly
Vir Biotechnology doses first patient in Phase 1 part 3 trial of VIR-5500
2M ago
VIR
Vir Biotechnology: Strategic Dual-Franchise Growth and Promising Oncology and HDV Developments Support Buy Rating
PremiumRatingsVir Biotechnology: Strategic Dual-Franchise Growth and Promising Oncology and HDV Developments Support Buy Rating
3M ago
VIR
Vir Biotechnology initiated with an Outperform at Evercore ISI
Premium
The Fly
Vir Biotechnology initiated with an Outperform at Evercore ISI
3M ago
VIR
MongoDB reports Q2 beat, Sompo to acquire Aspen Insurance: Morning Buzz
Premium
The Fly
MongoDB reports Q2 beat, Sompo to acquire Aspen Insurance: Morning Buzz
4M ago
BX
JD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >